Massimiliano Calabrese
Affiliations: | Department of Neurosciences, Biomedicine and Movement Sciences | University of Verona, Verona, Italy |
Google:
"Massimiliano Calabrese"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cagol A, Cortese R, Barakovic M, et al. (2023) Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis. Jama Neurology |
| Chisari CG, Bianco A, Brescia Morra V, et al. (2023) Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY). Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
| Magliozzi R, Howell OW, Calabrese M, et al. (2023) Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nature Reviews. Neurology |
| Gajofatto A, Cardobi N, Gobbin F, et al. (2023) Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity. Bmc Neurology. 23: 128 |
| Pezzini F, Pisani A, Mazziotti V, et al. (2023) Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF. International Journal of Molecular Sciences. 24 |
| Ziccardi S, Pisani AI, Schiavi GM, et al. (2023) Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. European Journal of Neurology |
| Ziccardi S, Pizzini FB, Guandalini M, et al. (2022) Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis. Bioengineering (Basel, Switzerland). 10 |
| Ponzano M, Schiavetti I, Bergamaschi R, et al. (2022) The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study. Multiple Sclerosis and Related Disorders. 68: 104243 |
| Andretta E, Finazzi Agrò E, Calabrese M, et al. (2022) Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data. Therapeutic Advances in Urology. 14: 17562872221122484 |
| Meaton I, Altokhis A, Allen CM, et al. (2022) Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221118677 |